학술논문

Durvalumab after chemoradiotherapy in patients with stage III non-small-cell lung cancer: real-world outcomes versus clinical trial results
Document Type
Journal
Source
IMMUNOTHERAPY; JUN 9 2023, 13p.
Subject
Language
English
ISSN
17507448